Firm
While the firm lost several litigators this month, Winston & Strawn is betting that its transatlantic merger will strengthen its IP practice
As trade secret filings rise due to AI development and economic espionage concerns, firms are relying on proactive counselling to help clients navigate disputes
IP firm leaders share why they remain positive in the face of falling patent applications from US filers, and how they are meeting a rising demand from China
Mathew Lucas has joined Pearce IP after spending more than 25 years at Qantm IP-owned firm Davies Collison Cave
Sponsored
Sponsored
-
Sponsored by MMXStuart Fuller, of corporate domain name management company BrandShelter, argues that trademark protection tools such as the AdultBlock will help brand owners to protect their revenues and reputations -
Sponsored by Daniel LawBrazil's legal system provides several options for IP owners to enforce their rights. Trade dress protection is not expressly foreseen in our law but falls within general unfair competition rules which basically forbid competitors to fraudulently divert third parties' clientele.
-
Sponsored by Liu, Shen & AssociatesThe global COVID-19 pandemic is affecting the world in various ways. One of the lessons we have learnt from this traumatic period is that while people always tried to find value in cooperation rather than in rivalry, cooperation could be more fragile than expected, especially in a multilateral scenario.
-
Sponsored by Remfry & SagarIn the second article from an exclusive series on the automotive industry, Pankaj Soni of Remfry & Sagar discusses patent protection in India
-
Sponsored by Spoor & FisherThe UK formally left the EU on January 31 2020, although there is a transitional period running until December 31 2020, and there is a chance that this may be extended. Much has been written about the consequences of Brexit for IP rights.
-
Sponsored by Griffith HackDespite being a market of only 26 million people, Australia possesses a world-class healthcare system and well regarded scientific community. This is most recently demonstrated through the participation of Australian scientists in the race to successfully manufacture a COVID-19 vaccine, and by the low infection death rates from the current pandemic in Australia.
